NNNN — Anbio Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- $4.49bn
- $4.48bn
- $8.19m
Annual cashflow statement for Anbio Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 2.54 | 10 | 2.25 | 2.37 |
| Depreciation | ||||
| Non-Cash Items | — | -0.039 | -0.163 | -0.337 |
| Unusual Items | ||||
| Changes in Working Capital | 1.65 | -5.53 | -1.2 | 0.045 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 4.18 | 4.45 | 0.898 | 2.08 |
| Other Investing Cash Flow Items | 0 | -1.53 | 1.73 | 0.337 |
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | 0 | -1.53 | 1.73 | 0.337 |
| Financing Cash Flow Items | — | 0 | -0.043 | -0.345 |
| Other Financing Cash Flow | ||||
| Cash from Financing Activities | — | 0 | -0.043 | -0.345 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 4.18 | 2.92 | 2.59 | 2.07 |